Respiratory diseases
potential biomarkers
way lung diseases
potential risk
substantial commercial potential
lung researchers
lung cancer
research instrument
PExA's instrument
new method
feasibility study
new Technological instrument
Exhaled Air
repeatable method
PExA method
objectives of BREATH project Phase1
health services
healthcare professionals
Healthcare markets
PExA's clients
checking system
patient's health conditions
significant burden of disease
chronic obstructive pulmonary disease
chemical changes
academia
asthma
small airways
user friendly
pharmaceutical companies
particles
patients
manufacture
stand-alone analysis
diagnostic device
existing methods
technical aspects
tuberculosis
Europe
simple breathing test
best alternative
deaths
quality
reliability
innovation
stage diagnosis
year
extensive costs
late-stages
competitiveness
profitability
outcome
disposable kits
activities of Phase
concept